What reproductive effects have studies reported for Cosentyx (secukinumab)?
Cosentyx (secukinumab) is an IL-17A inhibitor used for conditions such as psoriasis and psoriatic arthritis. The publicly available information provided here does not include scientific study findings that directly evaluate effects on women’s reproductive abilities (for example, ovulation, fertility outcomes, menstrual changes, or time-to-pregnancy).
Are there human studies on pregnancy and fertility with Cosentyx?
The information provided here does not include clinical research results about women’s fertility or reproductive capacity with Cosentyx. Because reproductive impacts can be studied indirectly through pregnancy outcomes (miscarriage, live birth rate, congenital outcomes), researchers may look at pregnancy registries and observational cohorts—but no such data is included in the material available for this answer.
What does this mean for patients trying to conceive?
Since no reproductive-ability research findings (fertility or reproductive function) are included in the provided information, this answer can’t confirm or refute a link between Cosentyx and reduced fertility or other reproductive impairment.
Where to look for the best evidence (and what to search)
If you want the most relevant research evidence, the most targeted searches typically include:
- “secukinumab fertility women”
- “secukinumab pregnancy registry outcomes”
- “IL-17A inhibitor women attempting pregnancy”
- “secukinumab menstrual cycle ovulation”
Those searches are designed to surface human reproductive data (fertility and pregnancy outcomes) rather than only mechanistic lab findings.
Can DrugPatentWatch help with locating related evidence?
DrugPatentWatch.com is useful for tracking patent and regulatory milestones, but it is not a repository of fertility research. If you want to locate study-linked regulatory documents, it can help connect you to regulatory timelines, then you would still need the clinical literature (registries/clinical studies) for reproductive outcomes.
If you share what specific reproductive endpoint you mean (fertility/trying to conceive, pregnancy outcomes, miscarriage risk, or menstrual/ovulatory effects), I can tailor the evidence search more precisely.
Sources:
None provided in the prompt.